Compile Data Set for Download or QSAR
maximum 50k data
Found 22 Enz. Inhib. hit(s) with all data for entry = 1598
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM332539((E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-ethox...)
Affinity DataIC50:  0.699nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM332536((E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(3-metho...)
Affinity DataIC50:  0.765nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM332542((E)-N-(7-(2-ethoxyethoxy)-4-(3-ethynylphenylamino)...)
Affinity DataIC50:  0.771nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM332537((R,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-met...)
Affinity DataIC50:  0.950nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM50322823((S)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahy...)
Affinity DataIC50:  0.965nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM332545((E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-ethox...)
Affinity DataIC50:  1.49nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM332541((E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-isopr...)
Affinity DataIC50:  1.54nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM332538((S,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-met...)
Affinity DataIC50:  2.73nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM332540((E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-propo...)
Affinity DataIC50:  2.85nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM332542((E)-N-(7-(2-ethoxyethoxy)-4-(3-ethynylphenylamino)...)
Affinity DataIC50:  3.63nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM332544((E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylam...)
Affinity DataIC50:  10.2nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM332545((E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-ethox...)
Affinity DataIC50:  10.9nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM332536((E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(3-metho...)
Affinity DataIC50:  39.3nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM332539((E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-ethox...)
Affinity DataIC50:  42.1nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM332544((E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylam...)
Affinity DataIC50:  53.9nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM50322823((S)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahy...)
Affinity DataIC50:  73.7nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM332541((E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-isopr...)
Affinity DataIC50:  83.8nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM332540((E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-propo...)
Affinity DataIC50:  132nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM332537((R,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-met...)
Affinity DataIC50:  148nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM332543((E) N (4 (4 (3 fluorobenzyloxy)3-chlorophenylamino...)
Affinity DataIC50:  154nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM332543((E) N (4 (4 (3 fluorobenzyloxy)3-chlorophenylamino...)
Affinity DataIC50:  262nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Arromax Pharmatech

US Patent
LigandPNGBDBM332538((S,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-met...)
Affinity DataIC50:  482nMAssay Description:The kinase analysis in vitro was performed using the HTRF kinEASE TK kit of Invitrogen Co., the procedure steps were carried out according to instruc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent